Corrigendum to "Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia" [Nanomedicine 40 (2022 Feb); 102480. doi : 10.1016/j.nano.2021.102480
| Errataetall: |
ErratumFor: Nanomedicine. 2022 Feb;40:102480. - PMID 34748962 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Nanomedicine : nanotechnology, biology, and medicine - 46(2022) vom: 12. Nov., Seite 102602 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salaheldin, Taher A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 31.10.2022 published: Print-Electronic ErratumFor: Nanomedicine. 2022 Feb;40:102480. - PMID 34748962 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.nano.2022.102602 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346687551 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346687551 | ||
| 003 | DE-627 | ||
| 005 | 20231226032042.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nano.2022.102602 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM346687551 | ||
| 035 | |a (NLM)36152475 | ||
| 035 | |a (PII)S1549-9634(22)00088-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salaheldin, Taher A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia" [Nanomedicine 40 (2022 Feb); 102480. doi |b 10.1016/j.nano.2021.102480 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 31.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Nanomedicine. 2022 Feb;40:102480. - PMID 34748962 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Godugu, Kavitha |e verfasserin |4 aut | |
| 700 | 1 | |a Bharali, Dhruba J |e verfasserin |4 aut | |
| 700 | 1 | |a Fujioka, Kazutoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Elshourbagy, Nabil |e verfasserin |4 aut | |
| 700 | 1 | |a Mousa, Shaker A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 46(2022) vom: 12. Nov., Seite 102602 |w (DE-627)NLM16062021X |x 1549-9642 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2022 |g day:12 |g month:11 |g pages:102602 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2022.102602 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2022 |b 12 |c 11 |h 102602 | ||